Vita launches 2 new restorative products
Vita has released two new products for its In-Ceram restorative materials: Vita In-Ceram YZ Disc Color and Vita In-Ceram YZ Disc HT (high translucent). Available
Vita has released two new products for its In-Ceram restorative materials: Vita In-Ceram YZ Disc Color and Vita In-Ceram YZ Disc HT (high translucent). Available
Transoral robotic surgery (TORS) may be an effective treatment for sufferers of obstructive sleep apnea/hypopnea syndrome (OSAHS), according to a recent study in Laryngoscope (July
The new Intraoral Brush (IOB) from Sulzer Mixpac is designed to allow dentists to combine two steps of the process for applying bonding and bleaching
Dear DrBicuspid Member, Are some oral and maxillofacial surgeons inadvertently overprescribing pain medications following impacted third-molar extractions? Yes, according to a new study in the
Align Technology has moved forward with the enforcement of permanent injunctions granted by the District Court of Düsseldorf in the Federal Republic of Germany against
Curasan, a company specializing in bone and tissue regeneration products, has acquired a large part of the oral regenerative medicine division of Riemser Pharma. Curasan
The Washington State dental board has approved the use of Botox and dermal fillers by general dentists. The Dental Quality Assurance Commission has affirmed the
Dentca has released EZ-Tracer sticker-based tracing sheets that simplify the centric relation (CR) capture process for accurate denture design. Once the EZ-Tracer is attached to
Children whose permanent and baby teeth are treated with fluoride varnish see a noticeable reduction in decayed, missing, and filled tooth surfaces, according to a
Pop stars have rekindled the dental gold grill trend favored by hip-hop artists in the 1980s and 1990s, but poorly made versions could hurt those
C3 Jian has successfully completed a phase I clinical trial for its C16G2 caries-fighting peptide drug. The randomized, double-blind, placebo-controlled trial included a dose-escalation period,
Tissue Regeneration Systems (TRS) has raised $4.6 million in venture capital funds to develop an implantable, resorbable scaffold to support weight-bearing stretches of bone in